Portfolio Holdings Detail for ISIN IE00B5BMR087

Stock Name / Fund	iShares Core S&P 500 UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CSP1(GBX) LSE
ETF Ticker	SXR8(EUR) F
ETF Ticker	CSP1.LS(GBX) CXE
ETF Ticker	CSPX.AS(EUR) CXE
ETF Ticker	CSPX.LS(USD) CXE
ETF Ticker	CSSPX.MI(EUR) CXE
ETF Ticker	CSSPXz(USD) CXE
ETF Ticker	SXR8.DE(EUR) CXE
ETF Ticker	CSSPX(EUR) ETF Plus
ETF Ticker	CSPX(EUR) Euronext Amsterdam
ETF Ticker	CSP1.L(GBP) LSE

Holdings detail for SYK

Show aggregate SYK holdings

News associated with SYK

Noteworthy ETF Inflows: VUG, BSX, SYK, APH

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Growth ETF (Symbol: VUG) where we have detected an approximate $1.9 billion dollar inflow -- that's a 1.0% increase week over week in outsta - 2025-09-09 11:51:27

Stryker Corporation (NYSE:SYK) Receives $430.10 Consensus Target Price from Brokerages

Shares of Stryker Corporation (NYSE:SYK – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the nineteen ratings firms that are presently covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average […] - 2025-09-08 02:50:50

Analysts Set Stryker Corporation (NYSE:SYK) Price Target at $430.10

Shares of Stryker Corporation (NYSE:SYK – Get Free Report) have earned a consensus rating of “Moderate Buy” from the nineteen brokerages that are presently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and fifteen have given a buy recommendation to the company. The average 1-year price […] - 2025-08-14 02:48:56

The Health Care Select Sector SPDR Fund Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $547.2 million dollar outflow -- that's a 1.7% decrease - 2025-08-12 11:56:08

4 GARP Stocks That Investors Can Scoop Up for Maximum Returns

Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. RL, SYK, RGLD and ADSK hold promise. - 2025-08-12 11:44:00

Noteworthy ETF Outflows: XLV, PFE, SYK, DHR

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $190.1 million dollar outflow -- that's a 0.6% decrease - 2025-08-04 11:50:53

After-Hours Earnings Report for July 31, 2025 : AAPL, AMZN, SYK, KLAC, MSTR, COIN, AJG, NET, RMD, MPWR, IR, LPLA

The following companies are expected to report earnings after hours on 07/31/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Apple Inc. (AAPL)is reporting for the quarter ending June 30, 2025. The computer company's consensus earnings per share fo - 2025-07-31 15:00:01

See Which Of The Latest 13F Filers Holds SYK

At Holdings Channel, we have reviewed the latest batch of the 28 most recent 13F filings for the 06/30/2025 reporting period, and noticed that Stryker Corp (Symbol: SYK) was held by 12 of these funds. When hedge fund managers appear to be thinking alike, we find it is a good ide - 2025-07-24 12:22:30

Noteworthy ETF Inflows: SCHX, HON, SYK, PANW

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab US Large-Cap ETF (Symbol: SCHX) where we have detected an approximate $119.3 million dollar inflow -- that's a 0.2% increase week over week in - 2025-07-24 11:48:21

Should You Buy or Sell Boston Scientific Stock Ahead of Its Upcoming Earnings?

Boston Scientific (NYSE:BSX) is scheduled to report its earnings on Wednesday, July 23, 2025. - 2025-07-23 16:13:59

Stryker Corporation (NYSE:SYK) Stock Position Raised by Edgestream Partners L.P.

Edgestream Partners L.P. boosted its position in shares of Stryker Corporation (NYSE:SYK – Free Report) by 27.0% during the 1st quarter, HoldingsChannel reports. The firm owned 893 shares of the medical technology company’s stock after buying an additional 190 shares during the quarter. Edgestream Partners L.P.’s holdings in Stryker were worth $332,000 at the end […] - 2025-07-21 04:56:50

Fund Update: GREENLEAF TRUST Just Disclosed New Holdings

GREENLEAF TRUST just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 06-30-2025 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-07-17 18:15:54

Should You Buy or Sell Abbott Laboratories Stock Ahead of Its Upcoming Earnings?

Abbott Laboratories (NYSE:ABT) is set to release its second-quarter earnings on Thursday, July 17, 2025. For event-driven traders, analyzing the stock’s historical reactions to earnings reports can provide valuable insights. - 2025-07-16 02:32:25

Allspring Global Investments Holdings LLC Sells 1,093 Shares of Stryker Corporation (NYSE:SYK)

Allspring Global Investments Holdings LLC reduced its stake in Stryker Corporation (NYSE:SYK – Free Report) by 2.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,368 shares of the medical technology company’s stock after selling 1,093 shares during the quarter. Allspring Global […] - 2025-07-03 05:31:05

Wednesday Sector Leaders: Technology & Communications, Healthcare

Looking at the sectors faring best as of midday Wednesday, shares of Technology & Communications companies are outperforming other sectors, losing just 0.2%. Within that group, Super Micro Computer Inc (Symbol: SMCI) and NVIDIA Corp (Symbol: NVDA) are two large stocks leadin - 2025-06-25 15:51:09

Analysts Set Stryker Corporation (NYSE:SYK) Target Price at $427.30

Shares of Stryker Corporation (NYSE:SYK – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nineteen research firms that are presently covering the company, Marketbeat.com reports. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating on the company. The average twelve-month target price […] - 2025-06-25 02:44:54

Advisor Resource Council Acquires New Stake in Stryker Corporation (NYSE:SYK)

Advisor Resource Council bought a new position in Stryker Corporation (NYSE:SYK – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 848 shares of the medical technology company’s stock, valued at approximately $316,000. Several other institutional investors and hedge funds […] - 2025-06-24 05:22:59

The Implied Analyst 12-Month Target For IVW

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-23 08:46:08

Robertson Stephens Wealth Management LLC Sells 284 Shares of Stryker Corporation (NYSE:SYK)

Robertson Stephens Wealth Management LLC lowered its holdings in Stryker Corporation (NYSE:SYK – Free Report) by 30.7% during the 1st quarter, HoldingsChannel.com reports. The firm owned 641 shares of the medical technology company’s stock after selling 284 shares during the quarter. Robertson Stephens Wealth Management LLC’s holdings in Stryker were worth $239,000 as of its […] - 2025-06-20 05:41:07

Stryker (NYSE:SYK) versus NAYA Biosciences (NASDAQ:NAYA) Financial Contrast

NAYA Biosciences (NASDAQ:NAYA – Get Free Report) and Stryker (NYSE:SYK – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability. Profitability This table compares NAYA Biosciences and Stryker’s net […] - 2025-06-20 04:26:53

Exchange Traded Concepts LLC Purchases 429 Shares of Stryker Corporation (NYSE:SYK)

Exchange Traded Concepts LLC lifted its position in shares of Stryker Corporation (NYSE:SYK – Free Report) by 6.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,692 shares of the medical technology company’s stock after purchasing an additional 429 […] - 2025-06-18 07:36:50

Trust Point Inc. Sells 894 Shares of Stryker Corporation (NYSE:SYK)

Trust Point Inc. reduced its stake in shares of Stryker Corporation (NYSE:SYK – Free Report) by 47.4% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 991 shares of the medical technology company’s stock after selling 894 shares during the period. Trust Point Inc.’s holdings in Stryker […] - 2025-06-18 05:11:09

Stryker Co. (NYSE:SYK) Shares Acquired by Ritholtz Wealth Management

Ritholtz Wealth Management raised its holdings in shares of Stryker Co. (NYSE:SYK – Free Report) by 5.2% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,598 shares of the medical technology company’s stock after acquiring an additional 276 shares during the quarter. […] - 2025-06-17 07:38:45

Dynamic Advisor Solutions LLC Takes Position in Stryker Co. (NYSE:SYK)

Dynamic Advisor Solutions LLC purchased a new stake in shares of Stryker Co. (NYSE:SYK – Free Report) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 6,388 shares of the medical technology company’s stock, valued at approximately $2,378,000. Several other hedge funds and other […] - 2025-06-17 05:46:52

Buy, Sell, Or Hold Boston Scientific Stock At $100?

Boston Scientific (NYSE:BSX) has seen its stock price surge over 30% in the past twelve months, significantly outpacing the S&P 500’s 9% gain. This impressive performance is attributed to new product launches, which have bolstered sales growth and expanded profit margin - 2025-06-17 03:35:45

Assenagon Asset Management S.A. Buys 110 Shares of Stryker Co. (NYSE:SYK)

Assenagon Asset Management S.A. lifted its stake in Stryker Co. (NYSE:SYK – Free Report) by 1.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,375 shares of the medical technology company’s stock after purchasing an additional 110 shares during […] - 2025-06-16 05:06:59

Focus Financial Network Inc. Takes $214,000 Position in Stryker Co. (NYSE:SYK)

Focus Financial Network Inc. purchased a new stake in Stryker Co. (NYSE:SYK – Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 576 shares of the medical technology company’s stock, valued at approximately $214,000. A number of other hedge funds and […] - 2025-06-15 05:58:52

5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off

Volatility is a part of life for long-term investors. The reasons the market goes up or down change, but the constant is that high-quality stocks, businesses that increasingly make more money over time, will reward investors if you wait long enough. - 2025-06-11 06:00:00

Vest Financial LLC Acquires New Holdings in Stryker Co. (NYSE:SYK)

Vest Financial LLC bought a new position in Stryker Co. (NYSE:SYK – Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 545 shares of the medical technology company’s stock, valued at approximately $203,000. Other institutional investors and hedge funds have also bought and sold shares […] - 2025-06-09 05:51:03

Notable ETF Outflow Detected - IXJ, SYK, DHR, MDT

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Global Healthcare ETF (Symbol: IXJ) where we have detected an approximate $116.0 million dollar outflow -- that's a 3.0% decrease week over - 2025-06-03 12:36:10

iShares Core S&P 500 UCITS ETF USD (Acc) SYK holdings

Date	Number of SYK Shares Held	Base Market Value of SYK Shares	Local Market Value of SYK Shares	Change in SYK Shares Held	Change in SYK Base Value	Current Price per SYK Share Held	Previous Price per SYK Share Held
2025-09-29 (Monday)	813,556	USD 300,918,093	USD 300,918,093
2025-09-26 (Friday)	813,133	USD 300,062,340	USD 300,062,340
2025-09-25 (Thursday)	812,614	USD 299,505,142	USD 299,505,142	658	USD -1,909,164	USD 368.57	USD 371.22
2025-09-24 (Wednesday)	811,956	USD 301,414,306	USD 301,414,306	-1,530	USD -5,953,244	USD 371.22	USD 377.84
2025-09-18 (Thursday)	813,486	USD 307,367,550	USD 307,367,550	48	USD 799,037	USD 377.84	USD 376.88
2025-09-17 (Wednesday)	813,438	USD 306,568,513	USD 306,568,513	432	USD 374,193	USD 376.88	USD 376.62
2025-09-16 (Tuesday)	813,006	USD 306,194,320	USD 306,194,320	192	USD -325,968	USD 376.62	USD 377.11
2025-09-15 (Monday)	812,814	USD 306,520,288	USD 306,520,288
2025-09-12 (Friday)	812,334	USD 311,400,116	USD 311,400,116

Share Trades of SYK by Blackrock for IE00B5BMR087

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-09-25	BUY	658			368.570*		379.94
2025-09-24	SELL	-1,530			371.220*		379.99 Profit of 581,385 on sale
2025-09-18	BUY	48			377.840*		380.00
2025-09-17	BUY	432			376.880*		380.02
2025-09-16	BUY	192			376.620*		380.04
2025-09-11	BUY	240			388.790*		379.99
2025-09-09	BUY	240			392.760*		379.90
2025-09-08	BUY	96			393.110*		379.82
2025-09-05	BUY	1,104			392.310*		379.75
2025-09-02	BUY	1,008			389.940*		379.69
2025-08-22	BUY	48			394.220*		379.61
2025-08-21	BUY	144			384.830*		379.58
2025-08-20	BUY	192			391.870*		379.50
2025-08-19	BUY	288			389.940*		379.44
2025-08-01	BUY	864			377.790*		379.45
2025-07-31	BUY	48			392.730*		379.37
2025-07-30	BUY	384			400.410*		379.24
2025-07-29	BUY	48			400.570*		379.11
2025-07-24	BUY	48			396.660*		379.01
2025-07-23	BUY	288			400.930*		378.87
2025-07-22	BUY	432			395.150*		378.77
2025-07-21	BUY	96			387.320*		378.72
2025-07-18	SELL	-480			389.400*		378.65 Profit of 181,752 on sale
2025-07-17	BUY	48			388.900*		378.58
2025-07-16	BUY	192			390.870*		378.51
2025-07-15	SELL	-735			390.590*		378.43 Profit of 278,145 on sale
2025-07-11	SELL	-96			389.460*		378.36 Profit of 36,322 on sale
2025-07-10	BUY	384			394.770*		378.25
2025-07-09	BUY	384			392.050*		378.16
2025-07-08	BUY	288			389.500*		378.09
2025-07-07	SELL	-1,104			392.510*		377.99 Profit of 417,302 on sale
2025-07-02	SELL	-1,392			391.810*		377.66 Profit of 525,708 on sale
2025-06-30	BUY	816			395.630*		377.54
2025-06-27	BUY	432			393.550*		377.43
2025-06-25	SELL	-96			392.230*		377.24 Profit of 36,215 on sale
2025-06-24	BUY	48			386.460*		377.17
2025-06-23	BUY	1,248			379.160*		377.16
2025-06-20	BUY	4,758			375.560*		377.17
2025-06-18	SELL	-282			373.260*		377.23 Profit of 106,378 on sale
2025-06-13	SELL	-141			377.300*		377.26 Profit of 53,193 on sale
2025-06-12	BUY	141			380.490*		377.23
2025-06-11	BUY	188			381.080*		377.20
2025-06-06	SELL	-235			383.890*		377.05 Profit of 88,608 on sale
2025-06-05	SELL	-141			383.100*		377.01 Profit of 53,158 on sale
2025-06-04	SELL	-188			382.550*		376.96 Profit of 70,869 on sale
2025-06-02	BUY	611			380.860*		376.90
2025-05-30	SELL	-138			382.640*		376.86 Profit of 52,006 on sale
2025-05-29	BUY	47			382.350*		376.81
2025-05-28	SELL	-47			380.390*		376.78 Profit of 17,709 on sale
2025-05-27	BUY	517			383.780*		376.73
2025-05-23	SELL	-940			376.620*		376.73 Profit of 354,125 on sale
2025-05-22	SELL	-1,034			378.280*		376.72 Profit of 389,524 on sale
2025-05-21	BUY	47			379.750*		376.69
2025-05-20	BUY	376			389.550*		376.58
2025-05-19	BUY	1,363			394.690*		376.43
2025-05-16	BUY	1,269			394.210*		376.27
2025-05-15	BUY	1,034			392.200*		376.13
2025-05-14	BUY	940			386.320*		376.05
2025-05-13	SELL	-188			387.530*		375.94 Profit of 70,677 on sale
2025-05-12	BUY	47			388.080*		375.84
2025-05-09	BUY	141			380.920*		375.79
2025-05-08	SELL	-1,363			382.460*		375.73 Profit of 512,119 on sale
2025-05-07	SELL	-658			384.060*		375.65 Profit of 247,179 on sale
2025-05-06	BUY	1,645			377.520*		375.64
2025-05-02	BUY	141			378.220*		375.56
2025-05-01	SELL	-235			373.990*		375.57 Profit of 88,259 on sale
2025-04-30	BUY	141			373.920*		375.59
2025-04-29	BUY	329			370.920*		375.63
2025-04-28	BUY	703			366.490*		375.72
2025-04-25	BUY	658			365.060*		375.83
2025-04-24	BUY	188			361.050*		375.98
2025-04-23	BUY	517			357.110*		376.17
2025-04-22	SELL	-284			348.120*		376.45 Profit of 106,913 on sale
2025-04-17	BUY	94			346.500*		377.47
2025-04-16	BUY	1,710			346.670*		377.80
2025-04-15	BUY	940			346.800*		378.13
2025-04-11	BUY	1,175			350.280*		378.71
2025-04-10	BUY	1,927			348.390*		379.05
2025-04-09	BUY	376			362.970*		379.23
2025-04-08	BUY	987			337.370*		379.70
2025-04-07	BUY	1,127			345.340*		380.10
2025-04-04	SELL	-2,820			345.800*		380.50 Profit of 1,073,002 on sale
2025-04-02	BUY	329			377.460*		380.53
2025-03-31	SELL	-1,269			372.250*		380.72 Profit of 483,133 on sale
2025-03-28	SELL	-799			364.500*		380.92 Profit of 304,353 on sale
2025-03-27	SELL	-235			367.540*		381.08 Profit of 89,554 on sale
2025-03-26	BUY	423			367.770*		381.25
2025-03-25	SELL	-564			372.870*		381.36 Profit of 215,084 on sale
2025-03-24	BUY	329			374.270*		381.45
2025-03-21	BUY	2,806			371.110*		381.58
2025-03-19	BUY	88			378.050*		381.73
2025-03-18	SELL	-846			375.910*		381.80 Profit of 323,006 on sale
2025-03-17	BUY	893			373.490*		381.92
2025-03-14	BUY	799			369.530*		382.09
2025-03-13	BUY	3,942			363.660*		382.35
2025-03-12	BUY	1,880			363.840*		382.61
2025-03-11	BUY	752			365.290*		382.87
2025-03-07	BUY	446			379.300*		383.11
2025-03-06	SELL	-423			382.310*		383.12 Profit of 162,060 on sale
2025-03-05	BUY	1,463			395.690*		382.93
2025-03-04	BUY	282			389.920*		382.82
2025-03-03	BUY	1,269			394.880*		382.63
2025-02-28	SELL	-329			386.190*		382.57 Profit of 125,865 on sale
2025-02-27	BUY	47			388.900*		382.47
2025-02-26	SELL	-94			391.740*		382.31 Profit of 35,937 on sale
2025-02-25	BUY	893			390.300*		382.18
2025-02-21	BUY	658			382.780*		382.06
2025-02-20	BUY	376			386.410*		381.99
2025-02-19	BUY	94			388.520*		381.87
2025-02-18	BUY	235			385.610*		381.80
2025-02-13	BUY	799			388.370*		381.54
2025-02-12	BUY	282			385.630*		381.45
2025-02-11	SELL	-94			390.480*		381.27 Profit of 35,839 on sale
2025-02-07	SELL	-376			391.400*		380.81 Profit of 143,186 on sale
2025-02-06	BUY	188			396.070*		380.48
2025-02-04	BUY	1,645			392.390*		379.79
2025-02-03	BUY	611			391.140*		379.52
2025-01-31	BUY	141			391.290*		379.24
2025-01-30	BUY	94			390.430*		378.97
2025-01-29	BUY	893			391.070*		378.67
2025-01-28	BUY	423			395.150*		378.25
2025-01-27	BUY	658			399.900*		377.68
2025-01-24	BUY	423			394.310*		377.23
2025-01-23	BUY	1,222			393.500*		376.78
2025-01-22	BUY	799			390.490*		376.38
2025-01-06	BUY	470			361.360*		376.83
2024-12-10	BUY	329			382.680*		376.65
2024-12-09	BUY	376			381.110*		376.51
2024-12-06	BUY	564			385.020*		376.23
2024-12-05	BUY	141			382.450*		376.03
2024-12-04	BUY	517			389.760*		375.55
2024-12-03	BUY	1,657			390.970*		375.00
2024-12-02	BUY	139			389.630*		374.46
2024-11-29	BUY	1,081			392.150*		373.78
2024-11-27	BUY	1,269			388.140*		372.58
2024-11-26	BUY	2,726			389.710*		371.84
2024-11-25	BUY	2,820			384.910*		371.25
2024-11-22	BUY	3,290			384.850*		370.60
2024-11-21	BUY	517			390.140*		369.62
2024-11-20	BUY	470			385.680*		368.78
2024-11-19	BUY	423			388.680*		367.67
2024-11-18	BUY	3,807			389.400*		366.39
2024-11-12	BUY	1,316			387.110*		365.10
2024-11-11	BUY	893			378.860*		364.18
2024-11-08	BUY	674			375.960*		363.34
2024-11-07	BUY	4,183			369.830*		362.84
2024-11-06	BUY	1,269			369.020*		362.32
2024-11-05	BUY	1,874			369.860*		361.64
2024-11-04	BUY	329			366.900*		361.11
2024-11-01	BUY	752			367.150*		360.44
2024-10-31	BUY	188			356.280*		360.96
2024-10-30	BUY	467			363.430*		360.61
2024-10-29	BUY	1,128			359.010*		360.87
2024-10-28	SELL	-329			356.010*		361.85 Profit of 119,047 on sale
2024-10-25	BUY	564			352.820*		364.10
2024-10-24	BUY	376			359.900*		365.50
2024-10-23	BUY	470			363.240*		366.63
2024-10-22	BUY	1,213			366.020*		367.25
2024-10-21	BUY	1,316			367.250*		0.00

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SYK

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer